Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Carmat

Start price
Target price
Perf. (%)
€26.30
16.11.21
-
16.11.22
-52.85%
17.11.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€21.24
15.11.21
€25.00
15.11.22
33.24%
27.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Genomic Vision S.A.

Start price
Target price
Perf. (%)
€0.30
12.11.21
€0.50
12.11.22
-78.55%
13.11.22

Could be worthwhile Investment >10% per year
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.24
12.11.21
-
12.11.22
10.49%
30.11.21

buy
Nanobiotix

Start price
Target price
Perf. (%)
€8.51
11.11.21
€10.00
11.11.22
-53.17%
12.11.22

Could be worthwhile Investment >10% per year
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.19
11.11.21
-
11.11.22
2.28%
17.11.21

Could be worthwhile Investment >10% per year
buy
bioMerieux S.A.

Start price
Target price
Perf. (%)
€106.50
08.11.21
€110.00
08.11.22
-12.21%
09.11.22

Could be worthwhile Investment >10% per year
bioMerieux S.A.

Start price
Target price
Perf. (%)
€107.60
07.11.21
€100.00
07.11.22
-1.02%
08.11.21

Could be worthwhile Investment >10% per year
Virbac S.A.

Start price
Target price
Perf. (%)
€401.50
07.11.21
€385.00
07.11.22
-38.36%
22.10.22

Could be worthwhile Investment >10% per year
Genoway S.A. Inh.

Start price
Target price
Perf. (%)
€4.37
07.11.21
€4.10
07.11.22
-19.68%
22.10.22

Could be worthwhile Investment >10% per year
buy
Mauna Kea Tech

Start price
Target price
Perf. (%)
€0.84
07.11.21
€1.10
07.11.22
-33.61%
08.11.22

Could be worthwhile Investment >10% per year
buy
Transgene S.A.

Start price
Target price
Perf. (%)
€2.43
07.11.21
€2.80
07.11.22
-20.58%
08.11.22

Could be worthwhile Investment >10% per year
buy
Valneva SE

Start price
Target price
Perf. (%)
€17.42
05.11.21
-
05.11.22
22.16%
14.11.21

buy
Valneva SE

Start price
Target price
Perf. (%)
€19.59
31.10.21
€30.00
31.10.22
8.63%
13.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
buy
Virbac S.A.

Start price
Target price
Perf. (%)
€395.50
25.10.21
€480.00
25.10.22
1.52%
07.11.21

Could be worthwhile Investment >10% per year
buy
Neovacs

Start price
Target price
Perf. (%)
€72,000
23.10.21
€640,000
23.10.22
11.11%
26.10.21

Could be worthwhile Investment >10% per year
Valneva SE

Start price
Target price
Perf. (%)
€19.02
22.10.21
€17.30
05.11.21
5.15%
05.11.21

buy
Biosynex

Start price
Target price
Perf. (%)
€15.66
20.10.21
€17.00
20.10.22
-21.52%
21.10.22

Could be worthwhile Investment >10% per year
Valneva SE

Start price
Target price
Perf. (%)
€15.87
18.10.21
-
18.10.22
7.88%
10.01.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€15.83
18.10.21
-
18.10.22
23.75%
31.10.21

Could be very worthwhile Investment >20% year
buy
Pixium Vision S.A.

Start price
Target price
Perf. (%)
€1.15
18.10.21
€2.00
18.10.22
-89.39%
19.10.22

Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
buy
Korian S.A.

Start price
Target price
Perf. (%)
€28.30
17.10.21
€30.00
17.10.22
-62.44%
18.10.22

Could be worthwhile Investment >10% per year
buy
Cellectis Nom.

Start price
Target price
Perf. (%)
€9.20
15.10.21
€11.50
15.10.22
-61.67%
07.08.22

Could be worthwhile Investment >10% per year
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€10.08
09.10.21
€12.00
09.10.22
-20.04%
26.11.21

Could be worthwhile Investment >10% per year